While everyone may benefit from a healthy diet, those with higher levels of Alzheimer's-related blood biomarkers may be more likely to benefit from a MIND diet intervention, according to a new study from the MIND trial. The biomarkers found in participants' blood measure two specific proteins central to Alzheimer's disease: beta-amyloid (or amyloid-β40) and phosphorylated tau (or p-tau181).